Koshinski Asset Management’s CONMED CNMD Stock Holding History

Koshinski Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13	Closed	-$1.93K	–	821
2022 Q1	$1.93K	Hold	13	–	–	﹤0.01%	1981
2021 Q4	$1.84K	Hold	13	–	–	﹤0.01%	2010
2021 Q3	$1.7K	Buy	+13	New	+$1.7K	﹤0.01%	2049

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Koshinski Asset Management's CNMD Position: Q2 2022 in Review

Koshinski Asset Management sold out of CONMED (CNMD) in Q2 2022, closing a stake of 13 shares — an estimated $1.93K sold.

Koshinski Asset Management first reported a position in CNMD in Q3 2021 and held it in 3 quarters. The position peaked at $1.93K in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

Koshinski Asset Management reported no remaining CONMED position as of Q2 2022 after selling out during the quarter.
Koshinski Asset Management sold 13 CONMED shares in Q2 2022, an estimated $1.93K.
Koshinski Asset Management first reported a position in CONMED in Q3 2021 and held it in 3 quarters.
Koshinski Asset Management's CONMED position peaked at $1.93K in Q1 2022.
280 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.